Abstract
5027^ Background: Abi (CYP17A1 and lyase inhibitor) and cabo (multi-tyrosine kinase inhibitor including MET and VEGFRs) have complementary mechanisms of action. Both have single agent activity in C...
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have